NEW YORK--(BUSINESS WIRE)--ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel cancer therapeutics, today announced that the Company is scheduled to present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference in New York, on Wednesday, February 6, 2008 at 3:20 p.m. EST. A corporate overview will be provided, including additional information on the Company’s product portfolio.
